Abstract:OBJECTIVE:To investigate the effect of early insulin therapy on the nuclear factor kappaB (NF-kappaB) pathway and inflammatory cytokine responses in skeletal muscle in type 2 diabetes mellitus (DM).METHODS:SD rats underwent intraperitoneal injection of streptozotocin to establish DM models and then divided into 5 groups: early un-treated group, early gliclazide treated group (receiving gliclazide since the third day after blood glucose increase for 3 weeks for 3 weeks), early insulin treated group (receiving insulin since the third day after blood glucose increase for 3 weeks for 3 weeks), late un-treated group, and late insulin treated group (receiving insulin since the fourth week after blood glucose increase for 3 weeks). By the end of treatment the rats were killed. Homogenate of skeletal muscle was made. The NF-kappaB P65 DNA binding was assayed by ELISA-based assay kit. Real time PCR was used to detect the mRNA expression levels of the gene of the cytokines: glucose transporter 4 (Glut4), inhibitor kappaB (IkappaBalpha), IL-1beta, IL-6, and tumor necrosis factor (TNF)-alpha. And Glut4 and IkappaBalpha protein expression levels were assayed by Western blotting.RESULTS:The Glut4 mRNA level in the skeletal muscle of the untreated DM rats decreased by 59% and the Glut4 protein level in the muscle cell membrane decreased by 69%. Insulin treatment and gliclazide treatment increased the Glut4 mRNA expression by 17% and 13% respectively, increased the Glut4 protein expression in cell membrane by 23% and 10% respectively, and decreased the Glut4 protein expression in the cytoplasm. In the DM rats the IkappaBalpha protein expression in the skeletal muscle was significantly lower (P < 0.05) and the NF-kappaB P65 DNA binding activity increased, and TNF-alpha, IL-1B, and IL-6 expression levels were up-regulated in comparison with the normal control group. Early treatment of insulin and gliclazide increased the IkappaBalpha protein expression, decreased the NF-kappaB P65 DNA binding activity and the TNF-alpha expression in the skeletal muscle.CONCLUSION:Early insulin treatment inhibits the NFkappaB activity and inflammatory cytokine responses in skeletal muscle that are involved in the amelioration of insulin resistance in type 2 DM. Such results may be due to indirect antiinflammatory effects of insulin relieving glucotoxicity and lipotoxicity in peripheral tissues.

Effects of Timely Insulin Treatment on Protection of Beta Cells in a Rat Model of Type 2 Diabetes Mellitus.

Insulin Improves Β-Cell Function in Glucose-Intolerant Rat Models Induced by Feeding a High-Fat Diet.

Effect of Early Insulin Therapy on Nuclear Factor Κb and Cytokine Gene Expressions in the Liver and Skeletal Muscle of High-Fat Diet, Streptozotocin-Treated Diabetic Rats

Insulin Therapy Improves Islet Functions by Restoring Pancreatic Vasculature in High-Fat Diet-Fed Streptozotocin-Diabetic Rats

Reversal of Streptozotocin-Induced Diabetes in Rats by Gene Therapy with Betacellulin and Pancreatic Duodenal Homeobox-1

Effects of Insulin Treatment on Intracellular Lipid Metabolism in Liver of Diabetic Rats

Protective Effects of Insulin on Islet B Cells in Newly Diagnosed Type 2 Diabetic Patients

Mild Hyperglycemia Triggered Islet Function Recovery in Streptozotocin-Induced Insulin-Deficient Diabetic Rats.

The experimental study of protection to βcell of obese rats and type-2 diabetic rats by Bezafibrate treatment

Effects of the Insulin Therapy on the Insulin Content and the Expression of Insulin in Pancreas of Diabetic Rats Fed with Prolonged High Fat Chow

Protective effects of insulin on erectile function in rats with streptozotocin-induced diabetes

Early insulin release effectively improves glucose tolerance: studies in two rodent models of type 2 diabetes mellitus

The Protect Effect of 1,25-(OH)_2D_3 on the Organ of the Type 1 Diabetes Mouse

[Effects of Early Insulin Therapy on Nuclear Factor Kappab Pathway in Skeletal Muscle of Diabetes: Experiment with Rats].

Activation of Angiotensin Type 2 Receptors Partially Ameliorates Streptozotocin-Induced Diabetes in Male Rats by Islet Protection

Protective Effects of Calorie Restriction on Insulin Resistance and Islet Function in STZ-induced Type 2 Diabetes Rats.

Effects of the insulin treatment on the lipid content in pancreas and on glucose-stimulated insulin secretion (GSIS) in diabetic rats fed high fat diet

Protective Effect of Recombinant Human Glucagon‐like Peptide‐1 (rhglp‐1) Pretreatment in STZ‐induced Diabetic Mice

Effects of Early Insulin Therapy on Sterol Regulatory Element Binding Protein 1 Pathway and Lipid Accumulation in Liver of Type 2 Diabetic Rats

Study of Co-Transplantation of Bone Marrow Mesenchymal Cells and Islets for Treating Type 1 Diabetes Mellitus in Sprague-Dawley Rats

Insulin protects against type 1 diabetes mellitus-induced ultrastructural abnormalities of pancreatic islet microcirculation